nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Carmustine—malignant glioma	0.66	1	CbGbCtD
Anagrelide—Fibrosis—Carmustine—malignant glioma	0.0141	0.0414	CcSEcCtD
Anagrelide—Pulmonary fibrosis—Carmustine—malignant glioma	0.00916	0.0269	CcSEcCtD
Anagrelide—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00885	0.026	CcSEcCtD
Anagrelide—Lung infiltration—Carmustine—malignant glioma	0.00859	0.0253	CcSEcCtD
Anagrelide—Interstitial pneumonia—Temozolomide—malignant glioma	0.00805	0.0237	CcSEcCtD
Anagrelide—Interstitial lung disease—Carmustine—malignant glioma	0.00569	0.0167	CcSEcCtD
Anagrelide—Interstitial lung disease—Temozolomide—malignant glioma	0.0055	0.0162	CcSEcCtD
Anagrelide—Influenza-like symptoms—Temozolomide—malignant glioma	0.00545	0.016	CcSEcCtD
Anagrelide—Hepatotoxicity—Carmustine—malignant glioma	0.00522	0.0153	CcSEcCtD
Anagrelide—Hepatotoxicity—Temozolomide—malignant glioma	0.00504	0.0148	CcSEcCtD
Anagrelide—Accidental injury—Carmustine—malignant glioma	0.00455	0.0134	CcSEcCtD
Anagrelide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00411	0.0121	CcSEcCtD
Anagrelide—Coordination abnormal—Carmustine—malignant glioma	0.0041	0.0121	CcSEcCtD
Anagrelide—Neck pain—Carmustine—malignant glioma	0.00408	0.012	CcSEcCtD
Anagrelide—Coordination abnormal—Temozolomide—malignant glioma	0.00396	0.0117	CcSEcCtD
Anagrelide—Urinary incontinence—Carmustine—malignant glioma	0.00389	0.0114	CcSEcCtD
Anagrelide—Influenza like illness—Temozolomide—malignant glioma	0.00378	0.0111	CcSEcCtD
Anagrelide—Urinary incontinence—Temozolomide—malignant glioma	0.00376	0.0111	CcSEcCtD
Anagrelide—Abnormal vision—Carmustine—malignant glioma	0.00351	0.0103	CcSEcCtD
Anagrelide—Abnormal vision—Temozolomide—malignant glioma	0.00339	0.00998	CcSEcCtD
Anagrelide—Injury—Carmustine—malignant glioma	0.00318	0.00935	CcSEcCtD
Anagrelide—Amnesia—Carmustine—malignant glioma	0.00311	0.00915	CcSEcCtD
Anagrelide—Amnesia—Temozolomide—malignant glioma	0.00301	0.00884	CcSEcCtD
Anagrelide—Diplopia—Carmustine—malignant glioma	0.00292	0.0086	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00292	0.0086	CcSEcCtD
Anagrelide—Diplopia—Temozolomide—malignant glioma	0.00283	0.00831	CcSEcCtD
Anagrelide—Liver function test abnormal—Carmustine—malignant glioma	0.0027	0.00794	CcSEcCtD
Anagrelide—Dehydration—Temozolomide—malignant glioma	0.00263	0.00773	CcSEcCtD
Anagrelide—Dry skin—Temozolomide—malignant glioma	0.00259	0.00762	CcSEcCtD
Anagrelide—Dysphagia—Carmustine—malignant glioma	0.00253	0.00743	CcSEcCtD
Anagrelide—Dysphagia—Temozolomide—malignant glioma	0.00244	0.00718	CcSEcCtD
Anagrelide—Pancytopenia—Carmustine—malignant glioma	0.0024	0.00706	CcSEcCtD
Anagrelide—Bronchitis—Temozolomide—malignant glioma	0.00235	0.00691	CcSEcCtD
Anagrelide—Pancytopenia—Temozolomide—malignant glioma	0.00232	0.00682	CcSEcCtD
Anagrelide—Dysuria—Temozolomide—malignant glioma	0.00228	0.00671	CcSEcCtD
Anagrelide—Pneumonia—Carmustine—malignant glioma	0.00227	0.00666	CcSEcCtD
Anagrelide—Pollakiuria—Temozolomide—malignant glioma	0.00226	0.00663	CcSEcCtD
Anagrelide—Erectile dysfunction—Temozolomide—malignant glioma	0.00225	0.00661	CcSEcCtD
Anagrelide—Depression—Carmustine—malignant glioma	0.00225	0.00661	CcSEcCtD
Anagrelide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00223	0.00655	CcSEcCtD
Anagrelide—Weight increased—Temozolomide—malignant glioma	0.00222	0.00653	CcSEcCtD
Anagrelide—Renal failure—Carmustine—malignant glioma	0.00221	0.00651	CcSEcCtD
Anagrelide—Weight decreased—Temozolomide—malignant glioma	0.00221	0.0065	CcSEcCtD
Anagrelide—Urinary tract infection—Carmustine—malignant glioma	0.00219	0.00644	CcSEcCtD
Anagrelide—Pneumonia—Temozolomide—malignant glioma	0.00219	0.00644	CcSEcCtD
Anagrelide—Depression—Temozolomide—malignant glioma	0.00217	0.00638	CcSEcCtD
Anagrelide—Urinary tract infection—Temozolomide—malignant glioma	0.00212	0.00622	CcSEcCtD
Anagrelide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00206	0.00606	CcSEcCtD
Anagrelide—Sinusitis—Temozolomide—malignant glioma	0.00204	0.00601	CcSEcCtD
Anagrelide—Haemoglobin—Carmustine—malignant glioma	0.00203	0.00598	CcSEcCtD
Anagrelide—Haemorrhage—Carmustine—malignant glioma	0.00202	0.00595	CcSEcCtD
Anagrelide—Hypoaesthesia—Carmustine—malignant glioma	0.00201	0.00592	CcSEcCtD
Anagrelide—Oedema peripheral—Carmustine—malignant glioma	0.00199	0.00586	CcSEcCtD
Anagrelide—Connective tissue disorder—Carmustine—malignant glioma	0.00199	0.00584	CcSEcCtD
Anagrelide—Haemoglobin—Temozolomide—malignant glioma	0.00196	0.00578	CcSEcCtD
Anagrelide—Hepatitis—Temozolomide—malignant glioma	0.00195	0.00575	CcSEcCtD
Anagrelide—Haemorrhage—Temozolomide—malignant glioma	0.00195	0.00575	CcSEcCtD
Anagrelide—Visual impairment—Carmustine—malignant glioma	0.00195	0.00573	CcSEcCtD
Anagrelide—Hypoaesthesia—Temozolomide—malignant glioma	0.00194	0.00572	CcSEcCtD
Anagrelide—Pharyngitis—Temozolomide—malignant glioma	0.00194	0.0057	CcSEcCtD
Anagrelide—Urinary tract disorder—Temozolomide—malignant glioma	0.00193	0.00568	CcSEcCtD
Anagrelide—Oedema peripheral—Temozolomide—malignant glioma	0.00193	0.00566	CcSEcCtD
Anagrelide—Connective tissue disorder—Temozolomide—malignant glioma	0.00192	0.00565	CcSEcCtD
Anagrelide—Urethral disorder—Temozolomide—malignant glioma	0.00192	0.00563	CcSEcCtD
Anagrelide—Eye disorder—Carmustine—malignant glioma	0.00189	0.00556	CcSEcCtD
Anagrelide—Visual impairment—Temozolomide—malignant glioma	0.00188	0.00554	CcSEcCtD
Anagrelide—Eye disorder—Temozolomide—malignant glioma	0.00183	0.00537	CcSEcCtD
Anagrelide—Tinnitus—Temozolomide—malignant glioma	0.00182	0.00536	CcSEcCtD
Anagrelide—Cardiac disorder—Temozolomide—malignant glioma	0.00181	0.00533	CcSEcCtD
Anagrelide—Arrhythmia—Carmustine—malignant glioma	0.00181	0.00531	CcSEcCtD
Anagrelide—Alopecia—Carmustine—malignant glioma	0.00179	0.00526	CcSEcCtD
Anagrelide—Mediastinal disorder—Temozolomide—malignant glioma	0.00176	0.00518	CcSEcCtD
Anagrelide—Malnutrition—Carmustine—malignant glioma	0.00176	0.00518	CcSEcCtD
Anagrelide—Chills—Temozolomide—malignant glioma	0.00175	0.00516	CcSEcCtD
Anagrelide—Alopecia—Temozolomide—malignant glioma	0.00173	0.00508	CcSEcCtD
Anagrelide—Back pain—Carmustine—malignant glioma	0.0017	0.00501	CcSEcCtD
Anagrelide—Malnutrition—Temozolomide—malignant glioma	0.0017	0.005	CcSEcCtD
Anagrelide—Vision blurred—Carmustine—malignant glioma	0.00166	0.00488	CcSEcCtD
Anagrelide—Back pain—Temozolomide—malignant glioma	0.00165	0.00484	CcSEcCtD
Anagrelide—Anaemia—Carmustine—malignant glioma	0.00163	0.00479	CcSEcCtD
Anagrelide—Vision blurred—Temozolomide—malignant glioma	0.0016	0.00472	CcSEcCtD
Anagrelide—Ill-defined disorder—Temozolomide—malignant glioma	0.00158	0.00464	CcSEcCtD
Anagrelide—Anaemia—Temozolomide—malignant glioma	0.00157	0.00462	CcSEcCtD
Anagrelide—Malaise—Temozolomide—malignant glioma	0.00153	0.00451	CcSEcCtD
Anagrelide—Convulsion—Carmustine—malignant glioma	0.00153	0.00449	CcSEcCtD
Anagrelide—Hypertension—Carmustine—malignant glioma	0.00152	0.00447	CcSEcCtD
Anagrelide—Palpitations—Temozolomide—malignant glioma	0.0015	0.00442	CcSEcCtD
Anagrelide—Myalgia—Carmustine—malignant glioma	0.0015	0.00441	CcSEcCtD
Anagrelide—Chest pain—Carmustine—malignant glioma	0.0015	0.00441	CcSEcCtD
Anagrelide—Cough—Temozolomide—malignant glioma	0.00148	0.00437	CcSEcCtD
Anagrelide—Convulsion—Temozolomide—malignant glioma	0.00147	0.00433	CcSEcCtD
Anagrelide—Hypertension—Temozolomide—malignant glioma	0.00147	0.00432	CcSEcCtD
Anagrelide—Confusional state—Carmustine—malignant glioma	0.00145	0.00426	CcSEcCtD
Anagrelide—Myalgia—Temozolomide—malignant glioma	0.00145	0.00426	CcSEcCtD
Anagrelide—Arthralgia—Temozolomide—malignant glioma	0.00145	0.00426	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00144	0.00423	CcSEcCtD
Anagrelide—Oedema—Carmustine—malignant glioma	0.00144	0.00423	CcSEcCtD
Anagrelide—Discomfort—Temozolomide—malignant glioma	0.00143	0.00421	CcSEcCtD
Anagrelide—Infection—Carmustine—malignant glioma	0.00143	0.0042	CcSEcCtD
Anagrelide—Dry mouth—Temozolomide—malignant glioma	0.00142	0.00417	CcSEcCtD
Anagrelide—Thrombocytopenia—Carmustine—malignant glioma	0.00141	0.00414	CcSEcCtD
Anagrelide—Tachycardia—Carmustine—malignant glioma	0.0014	0.00412	CcSEcCtD
Anagrelide—Confusional state—Temozolomide—malignant glioma	0.0014	0.00412	CcSEcCtD
Anagrelide—Oedema—Temozolomide—malignant glioma	0.00139	0.00408	CcSEcCtD
Anagrelide—Infection—Temozolomide—malignant glioma	0.00138	0.00406	CcSEcCtD
Anagrelide—Anorexia—Carmustine—malignant glioma	0.00137	0.00403	CcSEcCtD
Anagrelide—Nervous system disorder—Temozolomide—malignant glioma	0.00136	0.004	CcSEcCtD
Anagrelide—Thrombocytopenia—Temozolomide—malignant glioma	0.00136	0.004	CcSEcCtD
Anagrelide—Skin disorder—Temozolomide—malignant glioma	0.00135	0.00397	CcSEcCtD
Anagrelide—Hypotension—Carmustine—malignant glioma	0.00134	0.00395	CcSEcCtD
Anagrelide—Hyperhidrosis—Temozolomide—malignant glioma	0.00134	0.00395	CcSEcCtD
Anagrelide—Anorexia—Temozolomide—malignant glioma	0.00132	0.00389	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00131	0.00385	CcSEcCtD
Anagrelide—Insomnia—Carmustine—malignant glioma	0.0013	0.00382	CcSEcCtD
Anagrelide—Paraesthesia—Carmustine—malignant glioma	0.00129	0.00379	CcSEcCtD
Anagrelide—Dyspnoea—Carmustine—malignant glioma	0.00128	0.00377	CcSEcCtD
Anagrelide—Somnolence—Carmustine—malignant glioma	0.00128	0.00376	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00127	0.00372	CcSEcCtD
Anagrelide—Insomnia—Temozolomide—malignant glioma	0.00126	0.00369	CcSEcCtD
Anagrelide—Decreased appetite—Carmustine—malignant glioma	0.00125	0.00367	CcSEcCtD
Anagrelide—Paraesthesia—Temozolomide—malignant glioma	0.00125	0.00367	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00124	0.00365	CcSEcCtD
Anagrelide—Dyspnoea—Temozolomide—malignant glioma	0.00124	0.00364	CcSEcCtD
Anagrelide—Somnolence—Temozolomide—malignant glioma	0.00123	0.00363	CcSEcCtD
Anagrelide—Constipation—Carmustine—malignant glioma	0.00123	0.00361	CcSEcCtD
Anagrelide—Pain—Carmustine—malignant glioma	0.00123	0.00361	CcSEcCtD
Anagrelide—Dyspepsia—Temozolomide—malignant glioma	0.00122	0.00359	CcSEcCtD
Anagrelide—Decreased appetite—Temozolomide—malignant glioma	0.00121	0.00355	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0012	0.00353	CcSEcCtD
Anagrelide—Fatigue—Temozolomide—malignant glioma	0.0012	0.00352	CcSEcCtD
Anagrelide—Pain—Temozolomide—malignant glioma	0.00119	0.00349	CcSEcCtD
Anagrelide—Constipation—Temozolomide—malignant glioma	0.00119	0.00349	CcSEcCtD
Anagrelide—Feeling abnormal—Carmustine—malignant glioma	0.00118	0.00348	CcSEcCtD
Anagrelide—Gastrointestinal pain—Carmustine—malignant glioma	0.00117	0.00346	CcSEcCtD
Anagrelide—Feeling abnormal—Temozolomide—malignant glioma	0.00114	0.00336	CcSEcCtD
Anagrelide—Body temperature increased—Carmustine—malignant glioma	0.00114	0.00334	CcSEcCtD
Anagrelide—Abdominal pain—Carmustine—malignant glioma	0.00114	0.00334	CcSEcCtD
Anagrelide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00114	0.00334	CcSEcCtD
Anagrelide—Urticaria—Temozolomide—malignant glioma	0.0011	0.00324	CcSEcCtD
Anagrelide—Abdominal pain—Temozolomide—malignant glioma	0.0011	0.00323	CcSEcCtD
Anagrelide—Body temperature increased—Temozolomide—malignant glioma	0.0011	0.00323	CcSEcCtD
Anagrelide—Asthenia—Carmustine—malignant glioma	0.00103	0.00303	CcSEcCtD
Anagrelide—Asthenia—Temozolomide—malignant glioma	0.000996	0.00293	CcSEcCtD
Anagrelide—Diarrhoea—Carmustine—malignant glioma	0.000983	0.00289	CcSEcCtD
Anagrelide—Pruritus—Temozolomide—malignant glioma	0.000982	0.00289	CcSEcCtD
Anagrelide—Dizziness—Carmustine—malignant glioma	0.00095	0.00279	CcSEcCtD
Anagrelide—Diarrhoea—Temozolomide—malignant glioma	0.00095	0.00279	CcSEcCtD
Anagrelide—Dizziness—Temozolomide—malignant glioma	0.000918	0.0027	CcSEcCtD
Anagrelide—Vomiting—Carmustine—malignant glioma	0.000914	0.00269	CcSEcCtD
Anagrelide—Rash—Carmustine—malignant glioma	0.000906	0.00266	CcSEcCtD
Anagrelide—Dermatitis—Carmustine—malignant glioma	0.000905	0.00266	CcSEcCtD
Anagrelide—Headache—Carmustine—malignant glioma	0.0009	0.00265	CcSEcCtD
Anagrelide—Vomiting—Temozolomide—malignant glioma	0.000883	0.0026	CcSEcCtD
Anagrelide—Rash—Temozolomide—malignant glioma	0.000876	0.00257	CcSEcCtD
Anagrelide—Dermatitis—Temozolomide—malignant glioma	0.000875	0.00257	CcSEcCtD
Anagrelide—Headache—Temozolomide—malignant glioma	0.00087	0.00256	CcSEcCtD
Anagrelide—Nausea—Carmustine—malignant glioma	0.000853	0.00251	CcSEcCtD
Anagrelide—Nausea—Temozolomide—malignant glioma	0.000825	0.00243	CcSEcCtD
